Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1111/bjh.15685
- Subjects: LINFOMA; TRANSPLANTE HOMÓLOGO; CÉLULAS-TRONCO; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: British journal of haematology
- ISSN: 0007-1048
- Volume/Número/Paginação/Ano: v. 184, n. 4, p. 547-557, 2019
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
BRIERLEY, Charlotte K et al. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies. British journal of haematology, v. 184, n. 4, p. 547-557, 2019Tradução . . Disponível em: https://doi.org/10.1111/bjh.15685. Acesso em: 09 maio 2026. -
APA
Brierley, C. K., Jones, F. M., Hanlon, K., Peniket, A. J., Hatton, C., Collins, G. P., et al. (2019). Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies. British journal of haematology, 184( 4), 547-557. doi:10.1111/bjh.15685 -
NLM
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Rocha VG. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [Internet]. British journal of haematology. 2019 ; 184( 4): 547-557.[citado 2026 maio 09 ] Available from: https://doi.org/10.1111/bjh.15685 -
Vancouver
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Rocha VG. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [Internet]. British journal of haematology. 2019 ; 184( 4): 547-557.[citado 2026 maio 09 ] Available from: https://doi.org/10.1111/bjh.15685 - Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
